New York State Common Retirement Fund
WHWK

New York State Common Retirement Fund’s Whitehawk Therapeutics WHWK Stock Holding History

New York State Common Retirement Fund’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-141
Closed -$206 – 3366
2024
Q2 		$206 Sell
141
-10,590
-99% -$19.6K ﹤0.01% 3374
2024
Q1 		$25.1K Buy
10,731
+589
+6% +$1.14K ﹤0.01% 3119
2023
Q4 		$20.5K Sell
10,142
-23
-0.2% -$96 ﹤0.01% 3153
2023
Q3 		$49.2K Buy
10,165
+48
+0.5% +$279 ﹤0.01% 3029
2023
Q2 		$69.2K Hold
10,117
– – ﹤0.01% 3057
2023
Q1 		$73.2K Hold
10,117
– – ﹤0.01% 2899
2022
Q4 		$130K Sell
10,117
-5
-0% -$65 ﹤0.01% 2886
2022
Q3 		$143K Buy
10,122
+122
+1% +$1.6K ﹤0.01% 2899
2022
Q2 		$123K Buy
+10,000
New +$149K ﹤0.01% 2994

Other funds holding WHWK

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

New York State Common Retirement Fund's WHWK Position: Q3 2024 in Review

New York State Common Retirement Fund sold out of Whitehawk Therapeutics (WHWK) in Q3 2024, closing a stake of 141 shares — an estimated $206 sold.

New York State Common Retirement Fund first reported a position in WHWK in Q2 2022 and held it in 9 quarters. The position peaked at $143K in Q3 2022. 52 funds tracked by Wall St. Rank hold WHWK as of Q3 2024.

  • New York State Common Retirement Fund reported no remaining Whitehawk Therapeutics position as of Q3 2024 after selling out during the quarter.
  • New York State Common Retirement Fund sold 141 Whitehawk Therapeutics shares in Q3 2024, an estimated $206.
  • New York State Common Retirement Fund first reported a position in Whitehawk Therapeutics in Q2 2022 and held it in 9 quarters.
  • New York State Common Retirement Fund's Whitehawk Therapeutics position peaked at $143K in Q3 2022.
  • 52 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q3 2024.

Based on New York State Common Retirement Fund's 13F filing for Q3 2024, filed 28 Oct 2024.